IGF1 and cancer: While there are likely more than one mechanism for these improved outcomes and inhibition of ovarian cancer tumorogenesis, one of the mechanisms might be the regulation of deranged host energy balance by metformin related to adiposity, deregulated insulin-IGF-1 pathway or chronic inflammation, which is often observed in diabetic and cancer patients [46].